Development of Cytomegalovirus (CMV) Immune Recovery Uveitis Is Associated with Th17 Cell Depletion and Poor Systemic CMV-Specific T Cell Responses

Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these condit...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 52; no. 3; pp. 409 - 417
Main Authors Hartigan-O'Connor, Dennis J., Jacobson, Mark A., Tan, Qi Xuan, Sinclair, Elizabeth
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.02.2011
Subjects
Online AccessGet full text
ISSN1058-4838
1537-6591
1537-6591
DOI10.1093/cid/ciq112

Cover

Loading…
Abstract Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods. We examined CMV-specific T cell responses, regulatory T (T reg ) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results. Patients with CMV IRU had poor CMV-specific CD4 + T cell responses, as compared with control subjects, whereas CD8 + T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T reg cell function. Conclusions. The T reg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.
AbstractList The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ~16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. We examined CMV-specific T cell responses, regulatory T (T...) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Patients with CMV IRU had poor CMV-specific CD4... T cell responses, as compared with control subjects, whereas CD8+ T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T... cell function. The T... cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy. (ProQuest: ... denotes formulae/symbols omitted.)
We tested whether impaired systemic immunoregulation and hyperactive immune responses are associated with an immune reconstitution inflammatory syndrome, CMV IRU. We found instead that T-regs in CMV IRU patients are functionally intact, while virus-specific immune responses and Th17 cells are compromised Background . The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)–infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods . We examined CMV-specific T cell responses, regulatory T (T reg ) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results . Patients with CMV IRU had poor CMV-specific CD4 + T cell responses, as compared with control subjects, whereas CD8 + T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T reg cell function. Conclusions . The T reg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.
Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods. We examined CMV-specific T cell responses, regulatory T (T reg ) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results. Patients with CMV IRU had poor CMV-specific CD4 + T cell responses, as compared with control subjects, whereas CD8 + T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T reg cell function. Conclusions. The T reg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.
We tested whether impaired systemic immunoregulation and hyperactive immune responses are associated with an immune reconstitution inflammatory syndrome, CMV IRU. We found instead that T-regs in CMV IRU patients are functionally intact, while virus-specific immune responses and Th17 cells are compromised Background . The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in ∼16% of human immunodeficiency type 1 (HIV-1)–infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. Methods . We examined CMV-specific T cell responses, regulatory T (Treg) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. Results . Patients with CMV IRU had poor CMV-specific CD4+ T cell responses, as compared with control subjects, whereas CD8+ T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in Treg cell function. Conclusions . The Treg cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.
the immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in approximately16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution.BACKGROUNDthe immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in approximately16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution.we examined CMV-specific T cell responses, regulatory T (T(reg)) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU.METHODSwe examined CMV-specific T cell responses, regulatory T (T(reg)) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU.patients with CMV IRU had poor CMV-specific CD4(+) T cell responses, as compared with control subjects, whereas CD8(+) T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T(reg) cell function.RESULTSpatients with CMV IRU had poor CMV-specific CD4(+) T cell responses, as compared with control subjects, whereas CD8(+) T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T(reg) cell function.the T(reg) cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.CONCLUSIONSthe T(reg) cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.
the immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in approximately16% of human immunodeficiency type 1 (HIV-1)-infected patients given antiretroviral therapy. It has been proposed that these conditions are linked by a dysregulated immune system that is prone to exaggerated responses. However, immunologic studies have been limited by the availability of longitudinal samples from patients with IRIS and appropriate matched control subjects. Cytomegalovirus (CMV) immune recovery uveitis (IRU) is an IRIS occurring in up to 38% of patients with CMV retinitis. Although the pathologic immune responses occur in the eye, immune dysregulation that allows for development of pathologic responses is presumably caused by faulty systemic immune cell reconstitution. we examined CMV-specific T cell responses, regulatory T (T(reg)) cell function and polyclonal T cell responses, including IL-17 production, in 25 patients with CMV IRU and 49 immunorestored control subjects with CMV retinitis who did not develop IRU. patients with CMV IRU had poor CMV-specific CD4(+) T cell responses, as compared with control subjects, whereas CD8(+) T cell responses were comparable. Patients with CMV IRU were characterized by smaller numbers of circulating Th17 cells. Deficiency in anti-CMV responses was not associated with differences in T(reg) cell function. the T(reg) cell compartment is intact in patients with CMV IRU, and these patients do not develop exaggerated systemic CMV-specific or polyclonal immune responses. Cases are instead characterized by more profound depletion of Th17 cells and poor antiviral immune responses. CMV IRU may be most likely to develop in persons experiencing the greatest degree of immune dysfunction before initiating highly active antiretroviral therapy.
Author Hartigan-O'Connor, Dennis J.
Tan, Qi Xuan
Jacobson, Mark A.
Sinclair, Elizabeth
AuthorAffiliation 2 Positive Health Program, Department of Medicine, University of California, San Francisco
1 Division of Experimental Medicine
a Study group members are listed in supplementary appendix
AuthorAffiliation_xml – name: 2 Positive Health Program, Department of Medicine, University of California, San Francisco
– name: a Study group members are listed in supplementary appendix
– name: 1 Division of Experimental Medicine
Author_xml – sequence: 1
  givenname: Dennis J.
  surname: Hartigan-O'Connor
  fullname: Hartigan-O'Connor, Dennis J.
– sequence: 2
  givenname: Mark A.
  surname: Jacobson
  fullname: Jacobson, Mark A.
– sequence: 3
  givenname: Qi Xuan
  surname: Tan
  fullname: Tan, Qi Xuan
– sequence: 4
  givenname: Elizabeth
  surname: Sinclair
  fullname: Sinclair, Elizabeth
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23838739$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21189271$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1vFCEUhiemxn7ojfcaYmKqJqMwzCzMjUmz9WOTGk279ZYwzKHLZgamwKzZ39E_LJtdW22MXhAgPLy8nPMeZnvWWciypwS_Jbim75Rp07gmpHiQHZCKsnxS1WQvrXHF85JTvp8dhrDEmBCOq0fZfpEWdcHIQXZzCivo3NCDjchpNF1H18OV7NzK-DGgV9Mv31-jWd-PFtA5KLcCv0aXKzDRBDQL6CQEp4yM0KIfJi7QfEEYmkLXoVMYOojGWSRti74559HFOkTojUJJNb8YQBmdNvMtfw5hcDZAeJw91LIL8GQ3H2WXHz_Mp5_zs6-fZtOTs1xVhMe8bGpFNatpwXlTc0mVJqWuqcZcYyBFUWDGS4obpWvgSjVFK3ULBFghy2LS0KPs_VZ3GJseWpVK4GUnBm966dfCSSP-PLFmIa7cSlA8wZxPksDxTsC76xFCFL0JKv1FWnBjEJxzgie0Lv9PlqzgFalYIl_cI5du9DbVQfAqPUxKXifo-e_Oby3_6msCXu4AGZTstJdWmXDH0RQKRjdCb7ac8i4ED_oWIVhswiVSuMQ2XAnG92Blotx0OFXHdH-_svPhxuHf0s-23DJE5-98spowVpb0J1OD6cw
CODEN CIDIEL
CitedBy_id crossref_primary_10_1093_cid_cir276
crossref_primary_10_1093_ofid_ofz113
crossref_primary_10_1182_blood_2011_09_380840
crossref_primary_10_1016_j_revmed_2018_02_017
crossref_primary_10_4103_ijo_IJO_1583_20
crossref_primary_10_1097_ICU_0000000000001078
crossref_primary_10_1097_QCO_0b013e32834ab20a
crossref_primary_10_1097_QCO_0b013e328352b664
crossref_primary_10_1093_cid_ciu201
crossref_primary_10_3109_09273948_2013_779725
crossref_primary_10_1016_j_jiac_2017_03_002
crossref_primary_10_1097_TP_0b013e31828719c8
crossref_primary_10_1155_2014_971417
crossref_primary_10_1186_s12348_016_0110_3
crossref_primary_10_1007_s00430_015_0415_0
crossref_primary_10_1097_MD_0000000000006878
crossref_primary_10_1007_s00417_024_06415_y
crossref_primary_10_1016_j_jve_2021_100052
Cites_doi 10.1016/j.jim.2006.10.008
10.1128/CMR.00015-09
10.1097/01.aids.0000166100.36638.97
10.1002/eji.200838630
10.1086/525853
10.1182/blood-2010-05-286336
10.1097/QAD.0b013e328011efac
10.1016/S1473-3099(10)70026-8
10.1182/blood-2008-05-159301
10.1038/83713
10.1371/journal.ppat.1000295
10.1097/01.aids.0000202648.18526.bf
10.1086/342044
10.4049/jimmunol.155.3.1151
10.1016/S0002-9394(99)80149-4
10.1016/S0022-1759(03)00265-5
ContentType Journal Article
Copyright Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America
The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. 2011
2015 INIST-CNRS
Copyright University of Chicago, acting through its Press Feb 1, 2011
Copyright_xml – notice: Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America
– notice: The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. 2011
– notice: 2015 INIST-CNRS
– notice: Copyright University of Chicago, acting through its Press Feb 1, 2011
CorporateAuthor Studies of Ocular Complications of AIDS Research Group
CorporateAuthor_xml – name: Studies of Ocular Complications of AIDS Research Group
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T7
7U7
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
5PM
DOI 10.1093/cid/ciq112
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Health and Safety Science Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Toxicology Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Technology Research Database
Toxicology Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Virology and AIDS Abstracts

Health & Safety Science Abstracts


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1537-6591
EndPage 417
ExternalDocumentID PMC3060886
2273043771
21189271
23838739
10_1093_cid_ciq112
10.1093/cid/ciq112
27917744
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: P30AI027763
– fundername: NIAID NIH HHS
  grantid: K23 AI081540
– fundername: NCRR NIH HHS
  grantid: UL1 RR024131
– fundername: NIAID NIH HHS
  grantid: P30 AI027763
– fundername: NEI NIH HHS
  grantid: R21 EY018559
GroupedDBID ---
..I
.2P
.I3
.ZR
08P
0R~
1TH
29B
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
6J9
70D
AABZA
AACGO
AACZT
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABLJU
ABNHQ
ABOCM
ABPLY
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ACGFO
ACGFS
ACHIC
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADQBN
ADQXQ
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFIYH
AFOFC
AFRAH
AFXAL
AGINJ
AGORE
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQKUS
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C1A
C45
CDBKE
CS3
CZ4
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
E3Z
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H13
H5~
HAR
HW0
HZ~
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KSI
KSN
L7B
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
ODZKP
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TR2
W8F
X7H
YAYTL
YKOAZ
YXANX
~91
~S-
AASNB
ADACV
ADJQC
ADRIX
AFXEN
DOOOF
ESX
JSODD
M49
AAYXX
CITATION
.GJ
1KJ
3O-
AAPGJ
AAPNW
AAWDT
ABKDP
ABNGD
ABNKS
ABSMQ
ABZBJ
ACFRR
ACPQN
ACUKT
ACVCV
ACZBC
ADEYI
ADMTO
ADOCK
AEKPW
AFFQV
AFSHK
AFYAG
AGKEF
AGKRT
AGMDO
AGQPQ
AHGBF
AI.
AIJHB
AJDVS
APJGH
AQDSO
ASPBG
AVNTJ
AVWKF
AZFZN
BZKNY
EIHJH
FEDTE
HQ3
HTVGU
HVGLF
IQODW
J5H
MBLQV
N4W
OBFPC
O~Y
PB-
VH1
Y6R
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7T2
7T7
7U7
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
5PM
ID FETCH-LOGICAL-c518t-4b9c3f793288b98a3cf14f93f08f0e1222078430bcf9e8ccb2dafde1e72a426b3
ISSN 1058-4838
1537-6591
IngestDate Thu Aug 21 14:00:42 EDT 2025
Fri Jul 11 15:55:23 EDT 2025
Fri Jul 11 06:39:32 EDT 2025
Mon Jun 30 03:38:03 EDT 2025
Mon Jul 21 05:39:02 EDT 2025
Mon Jul 21 09:14:17 EDT 2025
Tue Jul 01 01:25:50 EDT 2025
Thu Apr 24 23:04:57 EDT 2025
Wed Sep 11 04:49:13 EDT 2024
Thu Jun 19 15:34:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Herpesviridae
Immune reconstitution
Uvea disease
Betaherpesvirinae
Human cytomegalovirus
Infection
Virus
Eye disease
Immunological investigation
Viral disease
T-Lymphocyte
Uveitis
Disseminated
Language English
License CC BY 4.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c518t-4b9c3f793288b98a3cf14f93f08f0e1222078430bcf9e8ccb2dafde1e72a426b3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3060886
PMID 21189271
PQID 853061489
PQPubID 48300
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3060886
proquest_miscellaneous_888106394
proquest_miscellaneous_847285157
proquest_journals_853061489
pubmed_primary_21189271
pascalfrancis_primary_23838739
crossref_primary_10_1093_cid_ciq112
crossref_citationtrail_10_1093_cid_ciq112
oup_primary_10_1093_cid_ciq112
jstor_primary_27917744
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-02-01
PublicationDateYYYYMMDD 2011-02-01
PublicationDate_xml – month: 02
  year: 2011
  text: 2011-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: United States
PublicationTitle Clinical infectious diseases
PublicationTitleAlternate Clin Infect Dis
PublicationYear 2011
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Mutimer ( key 20170425181130_bib11) 2002; 186
Kosobucki ( key 20170425181130_bib17) 2004; 137
Hartigan-O'Connor ( key 20170425181130_bib6) 2007; 319
Brenchley ( key 20170425181130_bib13) 2008; 112
Favre ( key 20170425181130_bib12) 2009; 5
Price ( key 20170425181130_bib1) 2009; 22
Ortega-Larrocea ( key 20170425181130_bib16) 2005; 19
Bennett ( key 20170425181130_bib7) 2001; 27
Muller ( key 20170425181130_bib2) 2010; 10
Jacobson ( key 20170425181130_bib8) 2008; 46
Betts ( key 20170425181130_bib9) 2003; 281
Seddiki ( key 20170425181130_bib5) 2009; 39
Bourgarit ( key 20170425181130_bib14) 2006; 20
Lawn ( key 20170425181130_bib3) 2007; 21
Nussenblatt ( key 20170425181130_bib4) 1998; 125
Barber ( key 20170425181130_bib15) 2010; 116
Sakaguchi ( key 20170425181130_bib10) 1995; 155
16511406 - AIDS. 2006 Jan 9;20(2):F1-7
18173357 - Clin Infect Dis. 2008 Feb 1;46(3):458-66
18664624 - Blood. 2008 Oct 1;112(7):2826-35
7636184 - J Immunol. 1995 Aug 1;155(3):1151-64
15059701 - Am J Ophthalmol. 2004 Apr;137(4):636-8
19822893 - Clin Microbiol Rev. 2009 Oct;22(4):651-63
12195359 - J Infect Dis. 2002 Sep 1;186(5):701-5
20656932 - Blood. 2010 Nov 4;116(18):3485-93
14580882 - J Immunol Methods. 2003 Oct 1;281(1-2):65-78
19180462 - Eur J Immunol. 2009 Feb;39(2):391-403
9512156 - Am J Ophthalmol. 1998 Mar;125(3):374-82
20334848 - Lancet Infect Dis. 2010 Apr;10(4):251-61
19214220 - PLoS Pathog. 2009 Feb;5(2):e1000295
17173927 - J Immunol Methods. 2007 Jan 30;319(1-2):41-52
15821403 - AIDS. 2005 Apr 29;19(7):735-8
11137993 - Nat Genet. 2001 Jan;27(1):20-1
17255740 - AIDS. 2007 Jan 30;21(3):335-41
References_xml – volume: 319
  start-page: 41
  year: 2007
  ident: key 20170425181130_bib6
  article-title: Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2006.10.008
– volume: 22
  start-page: 651
  year: 2009
  ident: key 20170425181130_bib1
  article-title: Immune restoration diseases reflect diverse immunopathological mechanisms
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.00015-09
– volume: 19
  start-page: 735
  year: 2005
  ident: key 20170425181130_bib16
  article-title: Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy
  publication-title: AIDS
  doi: 10.1097/01.aids.0000166100.36638.97
– volume: 39
  start-page: 391
  year: 2009
  ident: key 20170425181130_bib5
  article-title: Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200838630
– volume: 46
  start-page: 458
  year: 2008
  ident: key 20170425181130_bib8
  article-title: Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS
  publication-title: Clin Infect Dis
  doi: 10.1086/525853
– volume: 116
  start-page: 3485
  year: 2010
  ident: key 20170425181130_bib15
  article-title: Th1
  publication-title: Blood
  doi: 10.1182/blood-2010-05-286336
– volume: 21
  start-page: 335
  year: 2007
  ident: key 20170425181130_bib3
  article-title: Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328011efac
– volume: 10
  start-page: 251
  year: 2010
  ident: key 20170425181130_bib2
  article-title: Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(10)70026-8
– volume: 112
  start-page: 2826
  year: 2008
  ident: key 20170425181130_bib13
  article-title: Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
  publication-title: Blood
  doi: 10.1182/blood-2008-05-159301
– volume: 27
  start-page: 20
  year: 2001
  ident: key 20170425181130_bib7
  article-title: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
  publication-title: Nat Genet
  doi: 10.1038/83713
– volume: 5
  start-page: e1000295
  year: 2009
  ident: key 20170425181130_bib12
  article-title: Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000295
– volume: 20
  start-page: F1
  year: 2006
  ident: key 20170425181130_bib14
  article-title: Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients
  publication-title: AIDS
  doi: 10.1097/01.aids.0000202648.18526.bf
– volume: 186
  start-page: 701
  year: 2002
  ident: key 20170425181130_bib11
  article-title: Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response
  publication-title: J Infect Dis
  doi: 10.1086/342044
– volume: 137
  start-page: 636
  year: 2004
  ident: key 20170425181130_bib17
  article-title: Valganciclovir therapy for immune recovery uveitis complicated by macular edema
  publication-title: Am J Ophthalmol
– volume: 155
  start-page: 1151
  year: 1995
  ident: key 20170425181130_bib10
  article-title: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
  publication-title: J Immunol
  doi: 10.4049/jimmunol.155.3.1151
– volume: 125
  start-page: 374
  year: 1998
  ident: key 20170425181130_bib4
  article-title: Human immunodeficiency virus disease: changing patterns of intraocular inflammation
  publication-title: Am J Ophthalmol
  doi: 10.1016/S0002-9394(99)80149-4
– volume: 281
  start-page: 65
  year: 2003
  ident: key 20170425181130_bib9
  article-title: Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
  publication-title: J Immunol Methods
  doi: 10.1016/S0022-1759(03)00265-5
– reference: 15059701 - Am J Ophthalmol. 2004 Apr;137(4):636-8
– reference: 19214220 - PLoS Pathog. 2009 Feb;5(2):e1000295
– reference: 18173357 - Clin Infect Dis. 2008 Feb 1;46(3):458-66
– reference: 19180462 - Eur J Immunol. 2009 Feb;39(2):391-403
– reference: 7636184 - J Immunol. 1995 Aug 1;155(3):1151-64
– reference: 18664624 - Blood. 2008 Oct 1;112(7):2826-35
– reference: 20656932 - Blood. 2010 Nov 4;116(18):3485-93
– reference: 12195359 - J Infect Dis. 2002 Sep 1;186(5):701-5
– reference: 11137993 - Nat Genet. 2001 Jan;27(1):20-1
– reference: 9512156 - Am J Ophthalmol. 1998 Mar;125(3):374-82
– reference: 19822893 - Clin Microbiol Rev. 2009 Oct;22(4):651-63
– reference: 20334848 - Lancet Infect Dis. 2010 Apr;10(4):251-61
– reference: 15821403 - AIDS. 2005 Apr 29;19(7):735-8
– reference: 17255740 - AIDS. 2007 Jan 30;21(3):335-41
– reference: 17173927 - J Immunol Methods. 2007 Jan 30;319(1-2):41-52
– reference: 16511406 - AIDS. 2006 Jan 9;20(2):F1-7
– reference: 14580882 - J Immunol Methods. 2003 Oct 1;281(1-2):65-78
SSID ssj0011805
Score 2.1215475
Snippet Background. The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and...
We tested whether impaired systemic immunoregulation and hyperactive immune responses are associated with an immune reconstitution inflammatory syndrome, CMV...
the immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in...
The immune reconstitution inflammatory syndromes (IRIS) are a spectrum of inflammatory conditions associated with opportunistic infections and occurring in...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
oup
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 409
SubjectTerms Adult
Aged
AIDS
Anti-Retroviral Agents - adverse effects
Anti-Retroviral Agents - therapeutic use
Antiretroviral drugs
Biological and medical sciences
Cytokines
Cytomegalovirus
Cytomegalovirus - immunology
Cytomegalovirus - pathogenicity
Cytomegalovirus Infections - immunology
Cytomegalovirus Infections - pathology
Cytomegalovirus Infections - virology
Female
Highly active antiretroviral therapy
HIV
HIV Infections - complications
HIV Infections - drug therapy
HIV/AIDS
Human immunodeficiency virus
Humans
Immune Reconstitution Inflammatory Syndrome
Immune system
Immunology
Infectious diseases
Iris
Lymphocytes
Male
Medical sciences
Middle Aged
Nadir
Ophthalmology
T cell receptors
T lymphocytes
T-Lymphocyte Subsets - immunology
Th17 Cells - immunology
Tuberculosis
Uvea diseases
Uveitis
Uveitis - immunology
Uveitis - virology
Viral diseases
Vitamin deficiency
Title Development of Cytomegalovirus (CMV) Immune Recovery Uveitis Is Associated with Th17 Cell Depletion and Poor Systemic CMV-Specific T Cell Responses
URI https://www.jstor.org/stable/27917744
https://www.ncbi.nlm.nih.gov/pubmed/21189271
https://www.proquest.com/docview/853061489
https://www.proquest.com/docview/847285157
https://www.proquest.com/docview/888106394
https://pubmed.ncbi.nlm.nih.gov/PMC3060886
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQtw2yqCyBA9MVVguTpM8onbTOrZxS1Hfoti1tUgjKU07afwN_gI_lHPi3FqmcXmJmvjUsXS-2Occfz6HkFfKjK2B8rihxEwZTCnXiC0lDeYHseKwfsEdsi3OBkcTdjx1p53OzxZrabXkb8T3a8-V_I9W4RnoFU_J_oNm607hAfwG_cIVNAzXv9Jxi_FT0CqultlXCVN-dpksVkU4dXj6Bf3-MZ4CwQoNAhmbV_3JpcRcRv1xXuunoqGH55bXH2JEbyTnmJm7pCt_yLJFmd88EX3o1yhK1yu4CbX8J023LUmJVfaD6uRlxfqCcZWbQnkz-y0w00dqVMwbHUIYIfEmb_atjmHyrqqd4xGjJgwb6ijux6Q_XTVo_5yk4iJOFpvstTrKgWHbmjGiJ2bTLQKffnvmdu0WQp3WNMzMoLWil3e_LRY6kZYowCGSb1bJ517LyX32PjqcnJxE4cE0vEVu2-CMYJ2M0fhdvVdl-QVRth5hlQQ3cPah733d85rZo5mv1ZHKe_M4Bz0oXUjlOk9nk7DbsoDCB-R-6brQtxqHD0lHpo_IndOSnPGY_GjBkWaKbsCRvgbQ7FENRVpBkZZQpOOcNlCkCEWKUKQILVpDkQIUKUKRVlCkbSjSUMvXUHxCJocH4fDIKGt-GMK1_KXBeCAcBYuG7fs88GNHKIupwFGmr0xpgTULNi1zTC5UIH0huD2L1Uxa0rNjMDa5s0220iyVTwn1uMMZ2O8u45wFruK2lJ7JFBNc4u56l-xVKolEmRAf67JcRJqY4URY1Vqrr0te1rJznQbmWqntQrO1iO0FFvhXrEt6oOob_9lbQ0HTgwOI8pygS3YrWETlDJRHYGpjQMeHVlq3wvKAe35xKuGLjsD4tMGpcr0bRHzfQkcFRrmjYda8HcAd2J7VJd4aAGsBTE6_3pIm50WSehgZGDCDZ39-7S6523zxz8nWcrGSL8DSX_Je8aH9Ak3oBtc
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Cytomegalovirus+%28CMV%29+Immune+Recovery+Uveitis+Is+Associated+with+Th17+Cell+Depletion+and+Poor+Systemic+CMV-Specific+T+Cell+Responses&rft.jtitle=Clinical+infectious+diseases&rft.au=Hartigan-O%27Connor%2C+Dennis+J&rft.au=Jacobson%2C+Mark+A&rft.au=Tan%2C+Qi+Xuan&rft.au=Sinclair%2C+Elizabeth&rft.date=2011-02-01&rft.issn=1058-4838&rft.volume=52&rft.issue=3&rft.spage=409&rft.epage=409&rft_id=info:doi/10.1093%2Fcid%2Fciq112&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1058-4838&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1058-4838&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1058-4838&client=summon